<DOC>
	<DOCNO>NCT01800500</DOCNO>
	<brief_summary>This randomize clinical trial study interest smokeless tobacco product substitution cigarettes current smoker . Use smokeless tobacco product may help people stop smoking . Measuring use source nicotine cigarette variety different condition may help determine whether much smoker willing use substitution</brief_summary>
	<brief_title>Interest Smokeless Tobacco Product Substitution Cigarettes Current Smokers</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I. Systematically vary price , availability , product type , information product examine individual joint effect degree substitution smokeless product cigarette . II . Examine impact smokeless tobacco ( ST ) substitution biomarkers exposure ( carbon monoxide [ CO ] , cotinine ) . III . Explore relationship ST substitution measure mood health relate quality life . OUTLINE : Participants randomize 1 2 treatment arm . ARM I : Participants purchase ST product use fixed rate product price weekly record consumption ST product cigarettes smoked daily 3 week . ARM II : Participants purchase ST product use escalate product price weekly record consumption ST product cigarettes smoked daily 3 week . After completion study treatment , patient follow 6 month .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Lobeline</mesh_term>
	<criteria>Must report currently smoke least 10 cigarette per day smoking least 1 year Must planning quit smoke next 30 day , try quit last 30 day Must able read speak English Should concurrently use tobacco product nicotine medication Willing try new tobacco product substitute brand cigarettes Not current participate ongoing research study Must good general health Medically eligible receive nicotine replacement product ( base upon New York State [ NYS ] Smokers Quit line eligibility criterion ) No history heart attack stoke last 2 week No current use Zyban , bupropion , Wellbutrin , Chantix/varenicline , smoke cessation medication No history chest pain angina past month No report physician diagnose arrhythmia/irregular heartbeat , fast heartbeat , abnormal heart rate , use pacemaker No current report physician diagnose heart disease/coronary artery disease , high blood pressure ( systolic blood pressure [ SBP ] = 160 ; diastolic blood pressure [ DBP ] = 100 ) , stomach ulcer , diabetes , take pill depression asthma No selfreported chronic dental problem would interfere use oral product No use electronic cigarette ( ecigarette ) past 30 day No known sensitivity glycerol , propylene glycol , glycerin For female , currently pregnant breastfeeding ; plan become pregnant followup interval Prospective participant must also pass screen test substance use , administer orientation session , enter study ; substance use assess use Clinical Laboratory Improvement Amendments ( CLIA ) waive 7drug urine screen ( detect presence tetrahydrocannabinol [ THC ] , opiates , amphetamine , barbiturate , methamphetamine , phencyclidine [ PCP ] , lysergic acid diethylamide [ LSD ] ) ; participant must test negative 7 put study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>